260 related articles for article (PubMed ID: 26408304)
1. Designing a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trials.
Alden RS; Mandrekar SJ; Oxnard GR
Chin Clin Oncol; 2015 Sep; 4(3):37. PubMed ID: 26408304
[TBL] [Abstract][Full Text] [Related]
2. Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216).
Kehl KL; Zahrieh D; Yang P; Hillman SL; Tan AD; Sands JM; Oxnard GR; Gillaspie EA; Wigle D; Malik S; Stinchcombe TE; Ramalingam SS; Kelly K; Govindan R; Mandrekar SJ; Osarogiagbon RU; Kozono D
JAMA Oncol; 2022 May; 8(5):717-728. PubMed ID: 35297944
[TBL] [Abstract][Full Text] [Related]
3. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.
Li T; Kung HJ; Mack PC; Gandara DR
J Clin Oncol; 2013 Mar; 31(8):1039-49. PubMed ID: 23401433
[TBL] [Abstract][Full Text] [Related]
4. When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?
Mhanna L; Guibert N; Milia J; Mazieres J
Curr Treat Options Oncol; 2019 Jun; 20(7):60. PubMed ID: 31172347
[TBL] [Abstract][Full Text] [Related]
5. Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021.
Roberts TJ; Kesselheim AS; Avorn J
JAMA Netw Open; 2023 Jan; 6(1):e2252562. PubMed ID: 36696113
[TBL] [Abstract][Full Text] [Related]
6. Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer.
Zhao S; Zhang Z; Zhan J; Zhao X; Chen X; Xiao L; Wu K; Ma Y; Li M; Yang Y; Fang W; Zhao H; Zhang L
BMC Med; 2021 Oct; 19(1):223. PubMed ID: 34592968
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancer.
Lengel HB; Zheng J; Tan KS; Liu CC; Park BJ; Rocco G; Adusumilli PS; Molena D; Yu HA; Riely GJ; Bains MS; Rusch VW; Kris MG; Chaft JE; Li BT; Isbell JM; Jones DR
J Thorac Cardiovasc Surg; 2023 May; 165(5):1682-1693.e3. PubMed ID: 36528430
[TBL] [Abstract][Full Text] [Related]
8. Early-stage anaplastic lymphoma kinase (
Chen MF; Chaft JE
Transl Lung Cancer Res; 2023 Feb; 12(2):337-345. PubMed ID: 36895922
[TBL] [Abstract][Full Text] [Related]
9. Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
Morgensztern D; Campo MJ; Dahlberg SE; Doebele RC; Garon E; Gerber DE; Goldberg SB; Hammerman PS; Heist RS; Hensing T; Horn L; Ramalingam SS; Rudin CM; Salgia R; Sequist LV; Shaw AT; Simon GR; Somaiah N; Spigel DR; Wrangle J; Johnson D; Herbst RS; Bunn P; Govindan R
J Thorac Oncol; 2015 Jan; 10(1 Suppl 1):S1-63. PubMed ID: 25535693
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives.
Lee JM; McNamee CJ; Toloza E; Negrao MV; Lin J; Shum E; Cummings AL; Kris MG; Sepesi B; Bara I; Kurtsikidze N; Schulze K; Ngiam C; Chaft JE
J Thorac Oncol; 2023 Nov; 18(11):1458-1477. PubMed ID: 37451404
[TBL] [Abstract][Full Text] [Related]
11. Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection.
Park HK; Choi YD; Yun JS; Song SY; Na KJ; Yoon JY; Yoon CS; Oh HJ; Kim YC; Oh IJ
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067382
[TBL] [Abstract][Full Text] [Related]
12. Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the Block.
Liu J; Amini A; Govindarajan A; Abuali T; Mambetsariev I; Massarelli E; Villaflor V; Villalona-Calero M; West H; Williams T; Salgia R
JCO Precis Oncol; 2023 Sep; 7():e2200445. PubMed ID: 37656950
[TBL] [Abstract][Full Text] [Related]
13. Non-Small Cell Lung Cancer, Version 4.2024.
Riely GJ; Wood DE; Ettinger DS; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; DeCamp M; Desai AP; Dilling TJ; Dowell J; Durm GA; Gettinger S; Grotz TE; Gubens MA; Juloori A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Mullikin TC; Ng T; Owen D; Owen DH; Patel SP; Patil T; Polanco PM; Riess J; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory KM; Hang L
J Natl Compr Canc Netw; 2024 May; 22(4):249-274. PubMed ID: 38754467
[TBL] [Abstract][Full Text] [Related]
14. The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer.
Middleton G; Crack LR; Popat S; Swanton C; Hollingsworth SJ; Buller R; Walker I; Carr TH; Wherton D; Billingham LJ
Ann Oncol; 2015 Dec; 26(12):2464-9. PubMed ID: 26410619
[TBL] [Abstract][Full Text] [Related]
15. From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma.
Thomas A; Rajan A; Lopez-Chavez A; Wang Y; Giaccone G
Ann Oncol; 2013 Mar; 24(3):577-85. PubMed ID: 23131389
[TBL] [Abstract][Full Text] [Related]
16. Subgroup identification of targeted therapy effects on biomarker for time to event data.
Vishwakarma GK; Bhattacharjee A; Tank F; Pashchenko AF
Cancer Biomark; 2023; 38(4):413-424. PubMed ID: 37980650
[TBL] [Abstract][Full Text] [Related]
17. Trials to Overcome Drug Resistance to EGFR and ALK Targeted Therapies - Past, Present, and Future.
Spaans JN; Goss GD
Front Oncol; 2014; 4():233. PubMed ID: 25221748
[TBL] [Abstract][Full Text] [Related]
18. Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort.
Bruno R; Poma AM; Panozzi M; Lenzini A; Elia G; Zirafa CC; Aprile V; Ambrogi MC; Baldini E; Lucchi M; Melfi F; Chella A; Sbrana A; Alì G
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611088
[TBL] [Abstract][Full Text] [Related]
19. Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer.
Gregorc V; Mazzarella L; Lazzari C; Graziano P; Vigneri P; Genova C; Toschi L; Ciliberto G; Bonanno L; Delmonte A; Bucci G; Rossi A; Motta G; Coco S; Marinello A; Buglioni S; Cangi MG; Di Micco C; Bandiera A; Bonfiglio S; Pecciarini L; Guida A; Ceol A; Frige' G; De Maria R; Pelicci PG
Clin Lung Cancer; 2021 Jul; 22(4):e637-e641. PubMed ID: 33642178
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy for resected non-small cell lung cancer.
Wozniak AJ; Gadgeel SM
Ther Adv Med Oncol; 2009 Sep; 1(2):109-18. PubMed ID: 21789116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
